Alberto Alain Gabbai

Rua Pedro de Toledo 655, Vila Clemento, Sao Paulo, Brazil

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official

all conditions, ClinicalTrials.gov

NIH grants tied to them

NIH RePORTER

Trial papers

PubMed author-name match

Trials

Studies that name Alberto Alain Gabbai as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:26 UTC. Open this list on ClinicalTrials.gov

Ph3
NCT00957047 · Efficacy and Safety Study of BIA 2-093 in Combination With Other Anti-Epileptic Drugs to Treat Partial Epilepsy
Bial - Portela C S.A. · completed · Partial Epilepsy · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 05:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:26 UTC. The ranking covers the 200 most relevant of 11 PubMed records, and a shared surname and initials can bring in a namesake. All 11 on PubMed

The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison.
Lancet · 2007
205 citations
RCR 5.3
Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy.
Epilepsy Res · 2010
156 citations
RCR 6.1
Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: results of a 1-year open-label extension study.
Epilepsy Res · 2013
70 citations
RCR 3.4
Efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: integrated analysis of pooled data from double-blind phase III clinical studies.
Epilepsia · 2013
68 citations
RCR 3.0
Amitriptyline and aerobic exercise or amitriptyline alone in the treatment of chronic migraine: a randomized comparative study.
Arq Neuropsiquiatr · 2014
57 citations
RCR 2.9
Stereotactic biopsy guidance in adults with supratentorial nonenhancing gliomas: role of perfusion-weighted magnetic resonance imaging.
J Neurosurg · 2004
52 citations
RCR 1.5
The exercise test as a monitor of disease status in hypokalaemic periodic paralysis.
J Neurol Neurosurg Psychiatry · 2004
28 citations
RCR 0.8
Neurological outcomes in patients with ischemic stroke receiving enoxaparin or heparin for venous thromboembolism prophylaxis: subanalysis of the Prevention of VTE after Acute Ischemic Stroke with LMWH (PREVAIL) study.
Stroke · 2009
17 citations
RCR 0.5
Transesophageal echocardiography and transcranial doppler monitoring in coronary surgery without cardiopulmonary bypass: preliminary results.
Cerebrovasc Dis · 1999
11 citations
RCR 0.5
Is the number of microembolic signals related to neurologic outcome in coronary bypass surgery?
Arq Neuropsiquiatr · 2001
8 citations
RCR 0.3